Major Decisions On How NCI Will Spend Extra Money Won’t Be Made for Three-Four Months
In Brief: Twenty-Nine Percent Of Approved Organ Systems Applications Funded In February, May Cycles
Consensus Conference agrees That Nevi Can Be Precursors For Melanoma, Offers Management Suggestions
DCBD Board Rejects Breast Cancer Multiple Markers Concept Proposal
DRCCA Board Gets Tough on Concept Proposals, Okays Several Anyway
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Hegseth offers soldiers testosterone and FDA loosens safety warnings. Is the science there?
- FDA’s OCE publishes three final guidances to increase clinical trial enrollment
